the Synergistic Compatibility Framework
  • Home
  • What's Inside the Framework
  • SCF Developments
  • SCF Publications
  • SCF Systems Therapeutic’s AI Ecosystem

INTERCEPT ENGINE | Epigenomic–Chronobiologic–Autonomic Stabilization

SCF API Equivalent: NO-API-Θ1

PCR Mode: Preventative

Biological Target Domain:

Epigenomic drift
Circadian dysregulation
Autonomic nervous system instability

The intercept engine prevents initiation of neurodegenerative cascades by stabilizing upstream regulatory systems before mitochondrial and immune interventions occur.

1. SYSTEM PATHOGENESIS TARGET

Epigenomic Drift

Stress / toxin signaling
        ↓
AhR activation
        ↓
HDAC overactivity
        ↓
Plasticity gene suppression

Chronobiologic Collapse

SCN desynchronization
        ↓
Immune clock disruption
        ↓
Inflammatory bias

Autonomic Shock Priming

Sympathetic dominance
        ↓
Neuroimmune amplification
        ↓
Perfusion instability

2. FDA DRUG MAPPING

A. Epigenomic Plasticity Modulation

Drug
Mechanism
SCF Role
Valproate
Histone deacetylase inhibition
reopen transcriptional plasticity
Vorinostat
HDAC inhibition
normalize epigenomic repression

Justification

HDAC overactivity suppresses genes regulating:

  • synaptic plasticity
  • neuronal survival
  • mitochondrial repair

HDAC inhibition restores gene expression permissivity, enabling later restorative phases.

B. AhR Pathway Dampening

Drug
Mechanism
SCF Role
Omeprazole
weak AhR signaling modulation
reduce persistent transcriptional activation

Justification

Chronic AhR activation is associated with:

  • neuroinflammation
  • oxidative stress
  • mitochondrial impairment

Indirect modulation reduces persistent stress-response transcription loops.

C. Circadian Rhythm Stabilization

Drug
Mechanism
SCF Role
Melatonin
MT1/MT2 receptor agonism
circadian entrainment
Tasimelteon
selective melatonin receptor agonist
SCN synchronization

Justification

Circadian alignment restores:

  • immune tolerance
  • mitochondrial efficiency
  • glymphatic clearance

D. Autonomic Stabilization

Drug
Mechanism
SCF Role
Propranolol
beta-adrenergic blockade
sympathetic suppression
Ivabradine
sinus node modulation
heart-rate stabilization

Justification

Autonomic stabilization prevents neuroimmune shock amplification and stabilizes cerebral perfusion.

3. DOSE-TIER ARCHITECTURE (SCF MODEL)

The SCF protocol uses exposure tiers rather than fixed dosing.

Tier
Objective
Tier 1
minimal epigenomic reset
Tier 2
circadian stabilization
Tier 3
autonomic stabilization

Escalation occurs only when system stability criteria are met.

4. ESCALATION LOGIC

Escalation permitted when:

HRV stable
Sleep architecture normalized
Inflammatory markers stable

Escalation blocked when:

autonomic instability
sleep fragmentation
immune activation spike

5. BIOMARKER THRESHOLDS

Domain
Biomarker
Escalation Threshold
Circadian
melatonin amplitude
normalized rhythm
Autonomic
HRV (RMSSD)
stable or increasing
Inflammation
IL-6
non-rising
Stress axis
cortisol rhythm
diurnal pattern restored

6. STOP / HOLD RULES

Therapy paused if:

HRV collapse
persistent insomnia
inflammatory spike
cortisol dysregulation

7. INTERCEPT ENGINE OUTPUT

Successful intercept phase produces:

epigenomic plasticity restored
circadian alignment achieved
autonomic stability reached

This creates the biological permissive state required for the Stabilization Engine.

the Synergistic Compatibility Framework

About the Company

Contact

Regulatory Disclaimer

Terms of Use